Metrics to compare | 600812 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600812PeersSector | |
|---|---|---|---|---|
P/E Ratio | 49.4x | 18.1x | −0.4x | |
PEG Ratio | −21.66 | −0.48 | 0.00 | |
Price/Book | 1.4x | 1.5x | 2.6x | |
Price / LTM Sales | 0.9x | 1.6x | 3.1x | |
Upside (Analyst Target) | - | 39.9% | 48.3% | |
Fair Value Upside | Unlock | 22.8% | 6.1% | Unlock |
North China Pharmaceutical Company.Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company primarily offers anti-infective, biotechnology, and cardiovascular cerebrovascular drugs; and immunomodulators, vitamins, and health products. It also provides chemical, biological, agricultural, and biopharmaceuticals and veterinary drugs. It serves pharmaceutical distributors, agents, hospitals, chain pharmacies, and end-user clinics. North China Pharmaceutical Company.Ltd was founded in 1992 and is headquartered in Shijiazhuang, China.